 nigrostriat dopaminerg system vivo positron emiss tomographi healthi volunt subject patient parkinson diseas group healthi control subject patient parkinson diseas positron emiss tomographi tracer indic differ specif properti presynapt dopaminerg system caudat nucleu putamen first tracer -fluorodopa analog levodopa region brain uptak convers retent dopamin metabolit second tracer -nomifensin indic striatal monaminerg reuptak site dopaminerg tracer dopaminerg nerv termin densiti patient parkinson diseas striatal uptak tracer putamen affect caudat side-to-sid differ uptak putamen left-right differ score clinic motor perform -fluorodopa -nomifensin tracer uptak putamen averag normal valu substanti part cellular element dopaminerg nigrostriat system intact parkinsonian patient contrast extrem deplet endogen dopamin putamen patient postmortem result support search drug treatment nigrostriat cell loss diseas success suffici striatal nerv termin pool effect levodopa dopamin repletor